1. Home
  2. TOVX vs BBW Comparison

TOVX vs BBW Comparison

Compare TOVX & BBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.25

Market Cap

14.7M

Sector

Health Care

ML Signal

HOLD

BBW

Build-A-Bear Workshop Inc.

HOLD

Current Price

$34.07

Market Cap

444.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOVX
BBW
Founded
2001
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
444.3M
IPO Year
2012
2004

Fundamental Metrics

Financial Performance
Metric
TOVX
BBW
Price
$0.25
$34.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$1.00
$67.71
AVG Volume (30 Days)
1.4M
344.5K
Earning Date
05-13-2026
05-28-2026
Dividend Yield
N/A
2.51%
EPS Growth
89.07
5.00
EPS
N/A
3.99
Revenue
N/A
$357,866,000.00
Revenue This Year
N/A
$5.63
Revenue Next Year
N/A
$4.62
P/E Ratio
N/A
$8.95
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$34.08
52 Week High
$0.86
$75.77

Technical Indicators

Market Signals
Indicator
TOVX
BBW
Relative Strength Index (RSI) 36.63 37.33
Support Level $0.18 N/A
Resistance Level $0.27 $39.83
Average True Range (ATR) 0.03 2.00
MACD -0.01 -0.17
Stochastic Oscillator 4.77 1.69

Price Performance

Historical Comparison
TOVX
BBW

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments: Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, U.K., Ireland, and two e-commerce sites, the international franchising segment includes royalties and product and fixture sales from other international operations under franchise agreements, and the commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

Share on Social Networks: